Health Care Innovation
Drug Innovation
Issue Brief: Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
Pacific Research Institute
March 1, 2017
Commentary
Drug Importation Won’t Save Dollars Or Lives
A recent oped in The Hill by MedShadow Foundation founder Suzanne Robotti claims that permitting Americans to import prescription drugs from Canada would save dollars and lives. It would do neither. Prescription drug importation has several notable proponents, like Sens. John McCain (R-Ariz.), Amy Kobuchar (D-Minn.), and Bernie Sanders (I-Vt.), ...
Sally C. Pipes
February 24, 2017
Drug Pricing
Health Care Expert: If Obamacare Isn’t Immediately Repealed, Then It Likely Never Will Be
Ever since the Affordable Care Act — colloquially known as “Obamacare” — was signed into law in March 2010, the primary goal of congressional Republicans has been to repeal the law and replace it with a market-based solution that they say works for all Americans. For years, Republicans were only ...
Chris Enloe
January 19, 2017
Commentary
The New Senate’s Top Priority: Destroying Drug Innovation?
Minnesota Senator Amy Klobuchar just introduced a federal budget amendment that would legalize the importation of foreign prescription drugs. This particular policy change has long topped Democrats’ health care wish list, but shockingly, they might find support across the aisle this year, as President-elect Trump has spoken glowingly of importation. ...
Sally C. Pipes
January 10, 2017
Business & Economics
Drug Importation Is Not The Answer
The imminent repeal of the Affordable Care Act (aka Obamacare) is garnering most of the health care headlines, and rightly so. But, the focus on Obamacare should not overshadow other health care modifications that may be considered during the 115th Congress. Paramount among these proposals is the issue of drug ...
Wayne Winegarden
January 5, 2017
Health Care
Post-Election Top Policy Changes To Watch In 2017
While every new year brings change, with Donald Trump elected to become the next president and the U.S. House and Senate both having Republican majorities, managed healthcare executives will see more changes than usual in 2017—beginning with repealing and replacing most of the provisions in the Affordable Care Act (ACA). ...
Karen Appold
January 2, 2017
Agriculture
Free Market Policies Needed To Incentivize Creation Of New Life-Saving Treatments
The deaths of two patients at the Ronald Reagan UCLA Medical Center in early 2015 were blamed in part on a drug-resistant superbug. Two years earlier, the Centers for Disease Control and Prevention predicted that a “nightmare” was coming in the form of the killer bacteria carbapenem-resistant Enterobacteriaceae, also known ...
Kerry Jackson
December 19, 2016
Commentary
Trump And Clinton’s Healthcare Debate Was No Contest
Donald Trump’s penchant for brusque remarks came in handy during the second presidential debate, eight days ago. When the discussion turned to the president’s health law, the GOP candidate’s message was clear: “Obamacare is a disaster. You know it. We all know it.” Only Hillary’s own spouse put it better, ...
Sally C. Pipes
September 17, 2016
California
Health Care Needs Effective Reforms, Not the CREATES Act
Congress is back in session. With the election looming, this means a frenetic dash to pass bills on a number of big ticket items, including the budget and Zika funding. While the legislative fight over these issues will likely dominate the headlines, we cannot forget about other below-the-radar, but nevertheless ...
Wayne Winegarden
September 12, 2016
California
The high price of “cheap” drugs
California is losing the battle against opioid addiction. Every 45 minutes, someone in the Golden State overdoses. Fifty percent more people overdose today than in 2006. Fortunately, the Food and Drug Administration just approved the anti-addiction treatment Probuphine. It’s an implant placed in a person’s upper arm, where it releases ...
Sally C. Pipes
June 27, 2016
Issue Brief: Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
Drug Importation Won’t Save Dollars Or Lives
A recent oped in The Hill by MedShadow Foundation founder Suzanne Robotti claims that permitting Americans to import prescription drugs from Canada would save dollars and lives. It would do neither. Prescription drug importation has several notable proponents, like Sens. John McCain (R-Ariz.), Amy Kobuchar (D-Minn.), and Bernie Sanders (I-Vt.), ...
Health Care Expert: If Obamacare Isn’t Immediately Repealed, Then It Likely Never Will Be
Ever since the Affordable Care Act — colloquially known as “Obamacare” — was signed into law in March 2010, the primary goal of congressional Republicans has been to repeal the law and replace it with a market-based solution that they say works for all Americans. For years, Republicans were only ...
The New Senate’s Top Priority: Destroying Drug Innovation?
Minnesota Senator Amy Klobuchar just introduced a federal budget amendment that would legalize the importation of foreign prescription drugs. This particular policy change has long topped Democrats’ health care wish list, but shockingly, they might find support across the aisle this year, as President-elect Trump has spoken glowingly of importation. ...
Drug Importation Is Not The Answer
The imminent repeal of the Affordable Care Act (aka Obamacare) is garnering most of the health care headlines, and rightly so. But, the focus on Obamacare should not overshadow other health care modifications that may be considered during the 115th Congress. Paramount among these proposals is the issue of drug ...
Post-Election Top Policy Changes To Watch In 2017
While every new year brings change, with Donald Trump elected to become the next president and the U.S. House and Senate both having Republican majorities, managed healthcare executives will see more changes than usual in 2017—beginning with repealing and replacing most of the provisions in the Affordable Care Act (ACA). ...
Free Market Policies Needed To Incentivize Creation Of New Life-Saving Treatments
The deaths of two patients at the Ronald Reagan UCLA Medical Center in early 2015 were blamed in part on a drug-resistant superbug. Two years earlier, the Centers for Disease Control and Prevention predicted that a “nightmare” was coming in the form of the killer bacteria carbapenem-resistant Enterobacteriaceae, also known ...
Trump And Clinton’s Healthcare Debate Was No Contest
Donald Trump’s penchant for brusque remarks came in handy during the second presidential debate, eight days ago. When the discussion turned to the president’s health law, the GOP candidate’s message was clear: “Obamacare is a disaster. You know it. We all know it.” Only Hillary’s own spouse put it better, ...
Health Care Needs Effective Reforms, Not the CREATES Act
Congress is back in session. With the election looming, this means a frenetic dash to pass bills on a number of big ticket items, including the budget and Zika funding. While the legislative fight over these issues will likely dominate the headlines, we cannot forget about other below-the-radar, but nevertheless ...
The high price of “cheap” drugs
California is losing the battle against opioid addiction. Every 45 minutes, someone in the Golden State overdoses. Fifty percent more people overdose today than in 2006. Fortunately, the Food and Drug Administration just approved the anti-addiction treatment Probuphine. It’s an implant placed in a person’s upper arm, where it releases ...